Gilead Sciences, Inc.
เพิ่มขึ้น

Gilead ready for Lift-Off Target1: 123.27 Target2: 140 Stop: 93

Consistent outperformer with always an Ace up its sleeve. Expect at least a 30% increase in value in 2016. You will never see this stock at these prices ever again. Buy now and thank me Later. All bets are off if we have a financial collapse dragging the share price below 92.96.
bigpharmadrugsearningswinnerStocks

คำจำกัดสิทธิ์ความรับผิดชอบ